Principal Securities, Inc. Adma Biologics, Inc. Transaction History
Principal Securities, Inc.
- $4.14 Trillion
- Q3 2024
A detailed history of Principal Securities, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 22 shares of ADMA stock, worth $468. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22Holding current value
$468% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$397 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$386 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$277 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$269 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$183 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.18B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...